Welcome to our dedicated page for 3D Systems news (Ticker: DDD), a resource for investors and traders seeking the latest updates and insights on 3D Systems stock.
3D Systems Corp (symbol: DDD) is a pioneer in the 3D printing industry, offering a broad array of 3D printing and digital manufacturing solutions. The company's product portfolio includes 3D printers for plastics and metals, materials, software, on-demand manufacturing services, and digital design tools. With over 35 years of experience, 3D Systems is at the forefront of innovation in additive manufacturing, impacting a wide range of industries from healthcare and dental to aerospace, automotive, and durable goods.
3D Systems' operations are segmented into Healthcare Solutions and Industrial Solutions, with a significant portion of its revenue generated from the Industrial segment. The company has a strong global presence with offices and facilities across the Americas, EMEA, and APAC regions, although the majority of its revenue comes from the Americas.
The company's recent projects have showcased its advanced capabilities in both industrial and healthcare applications. For instance, 3D Systems has pioneered a first-to-market solution for jetted, monolithic dentures, combining bespoke materials to deliver high-performance dental prosthetics. This innovation has gained interest from leading dental labs and is expected to receive FDA clearance in the second half of 2024.
On the industrial front, 3D Systems continues to expand its portfolio. Recently, the company has seen growth in its metal 3D printing division with Wilting, an industrial machining and metal 3D printing service provider, adding multiple DMP Flex 350 metal 3D printers to its production line. This expansion will enable Wilting to meet increasing customer demand more efficiently.
Financially, 3D Systems has been proactive in managing its liabilities and maintaining a strong balance sheet. The company recently entered into repurchase agreements to buy back $110 million of its 0% Convertible Senior Notes due 2026, thereby reducing its outstanding debt significantly.
3D Systems' commitment to innovation is further exemplified by its developments in patient-specific medical devices. The FDA recently cleared its VSP® PEEK Cranial Implant solution, designed for use in cranioplasty procedures, which utilizes additive manufacturing to produce highly customized, cost-effective cranial implants.
Looking ahead, 3D Systems aims to harness its leadership in digital dentistry, with plans to expand its product offerings to include night guards and direct-printed clear aligners. The company has also secured a multi-year purchase agreement, valued at nearly a quarter-billion dollars, to support the indirect manufacturing process for clear aligners, a testament to its robust 3D printing technology and market leadership.
3D Systems' unique combination of hardware, software, materials, and services, powered by expert application engineers, ensures they continue to transform industries and empower their customers to innovate. More information on 3D Systems is available at www.3dsystems.com.
3D Systems has launched the ProJet MJP 2500W Plus, a cutting-edge 3D printer tailored for the jewelry manufacturing sector, valued at $25 billion. This innovative machine boasts a 2x improvement in vertical resolution and enhances throughput by 25%, allowing for faster production of 100% wax casting patterns. The printer minimizes the need for costly manual polishing, reducing precious metal waste and increasing profitability for users. Designed for high-quality and complex jewelry designs, it supports rapid design iterations and mass customization, aligning with the growing demand in the jewelry additive manufacturing market.
3D Systems (NYSE: DDD) appointed Dr. Rebekah Gee to its Medical Advisory Board, effective March 1, 2023. Dr. Gee, a public health policy expert and former Secretary of the Louisiana Department of Health, brings extensive experience in healthcare innovation and policy implementation. The advisory board, established in May 2022, aims to guide the company's regenerative medicine initiatives, focusing on advanced 3D printing technologies for human organ production and related applications. Dr. Gee's insights will be pivotal for navigating healthcare delivery challenges, including patient insurance and reimbursement issues, supporting 3D Systems' strategic goals in the medical sector.
3D Systems (NYSE:DDD) has announced the release date for its fourth quarter and full year 2022 financial results, scheduled for February 28, 2023. A conference call to discuss these results will take place on March 1, 2023, at 8:30 a.m. Eastern Time. Investors can access the call via telephone or listen to a live webcast on the company's investor relations website. 3D Systems has over 35 years of experience in 3D printing, providing innovative solutions across various industries including healthcare and aerospace. For more details, visit their investor relations page.
3D Systems (NYSE: DDD) has formed a three-year technical partnership with Stewart-Haas Racing, aimed at enhancing the racing team's engineering capabilities. Utilizing 3D Systems' ProX 800 and Figure 4 printers, the partnership will facilitate rapid design and production of crucial components, improving the speed and performance of racecars. This collaboration allows for quicker iteration on designs and prototyping, essential for attaining a competitive edge. The partnership officially commences with the NASCAR Xfinity Series race at Daytona on February 18, 2023.
3D Systems (NYSE:DDD) announced that rms Company, a leading medical device manufacturer, has integrated the DMP Flex 350 Dual into its production process. This addition increases productivity by up to 50%, enhancing rms' powder to package capabilities and expanding the range of implants produced. With over 30 DMP printers, rms is positioned to innovate and streamline the manufacturing of high-quality, tight-tolerance medical devices, particularly titanium implants. The DMP Flex 350 Dual's dual-laser system allows for greater efficiency without compromising precision, aligning with current industry demands.
3D Systems (NYSE:DDD) appointed Mr. Bert Bruce to its Medical Advisory Board to enhance its regenerative medicine initiatives. The board aims to guide efforts in 3D printing vascularized tissues for organ manufacturing and drug development, potentially reducing animal trials. Mr. Bruce, leading the Rare Disease Business Unit at Pfizer, brings over 30 years of pharmaceutical experience. He has a strong background in drug discovery and commercialization. Dr. Jeffrey Graves, CEO, highlighted Bruce's expertise as vital for accelerating the company’s advancements in regenerative medicine and related technologies.
3D Systems (NYSE: DDD) has appointed Dr. Joe Zuiker as Executive Vice President, Engineering and Operations, effective December 12, 2022. Dr. Zuiker brings extensive experience in technical leadership across various industries. Alongside him, Dr. Brent Stucker has been elevated to Chief Technology Officer for Additive Manufacturing. This leadership change aims to bolster 3D Systems' position in the additive manufacturing sector and enhance its product development capabilities as demand for 3D printing increases among customers.
3D Systems (NYSE: DDD) has announced a strategic partnership with Wematter, becoming the exclusive worldwide distributor of the Wematter Gravity Selective Laser Sintering (SLS) solution. This compact, affordable SLS system, designed for diverse applications including medical and automotive industries, occupies less space while delivering a larger build volume. The Gravity allows for easy installation, cloud connectivity, and efficient recycling of materials, offering a cost-effective solution for manufacturers. It will be expanded to the Americas and Asia Pacific by Q2 2023.
3D Systems (NYSE: DDD) has introduced two new materials, Certified HX and Certified CuCr2.4, enhancing its materials portfolio for 3D printing. Certified HX is a high-performance nickel alloy, ideal for high-temperature applications up to 1200°C, while Certified CuCr2.4 offers improved strength and conductivity for cooling systems. Both materials are optimized for use with DMP Flex 350 and DMP Factory 350 printers. These innovations aim to meet the increasing demands in industries like energy, aerospace, and automotive, showcasing 3D Systems' commitment to advancing additive manufacturing technology.
3D Systems (NYSE: DDD) has partnered with ALM to include DuraForm® PAx in ALM's materials portfolio. This innovative nylon copolymer is aimed at industrial applications, offering lower costs and high recyclability. DuraForm PAx is engineered for high impact and elongation performance, making it suitable for diverse applications such as orthotics and tooling. The collaboration enhances material options for customers using Selective Laser Sintering (SLS) technologies and signifies a commitment to innovation in additive manufacturing. Both companies will showcase this material at Formnext 2022.
FAQ
What is the current stock price of 3D Systems (DDD)?
What is the market cap of 3D Systems (DDD)?
What does 3D Systems Corp do?
What are the main segments of 3D Systems' business?
What recent innovations has 3D Systems introduced?
How is 3D Systems expanding its digital dentistry portfolio?
What is the significance of 3D Systems' recent debt repurchase?
How does 3D Systems impact the healthcare industry?
What are some of the industries served by 3D Systems?
Where does 3D Systems generate most of its revenue?
What is 3D Systems' approach to supporting customer demand?
How long has 3D Systems been in the 3D printing industry?
